FDA Approved: ZEPATIER — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved ZEPATIER, a fixed-dose combination of elbasvir and grazoprevir, for the treatment of chronic hepatitis C virus infection in adults with genotypes 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Zepatier (elbasvir/grazoprevir)

Snippet

ORIG AP for ZEPATIER (ELBASVIR AND GRAZOPREVIR)